Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

771
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
771
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.9K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.9K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

369
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
369
Neurotransmitters01:31

Neurotransmitters

2.1K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
2.1K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

569
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
569
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

2.1K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reimagining pharmacology education.

Pharmacological reviews·2026
Same author

Development and Validation of Pharmacology Concept Inventory for Concept-Based Learning: Leveraging Theory, Expert Insights, and Student Perspectives.

Pharmacology research & perspectives·2026
Same author

Using assessment in pharmacology to drive learning in the right direction.

British journal of clinical pharmacology·2026
Same author

The behavioural, toxicological, and biochemical effects of caffeine on Lumbriculus variegatus.

Environmental toxicology and pharmacology·2026
Same author

Correction: IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): a small animal acute myocardial infarction randomized-controlled multicenter study on the effect of ischemic preconditioning.

Basic research in cardiology·2025
Same author

Deciphering the Language of Assessment in Pharmacology Summative Written Assessments.

Pharmacology research & perspectives·2025

Related Experiment Video

Updated: Nov 25, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.3K

Ethanolamine: A Potential Promoiety with Additional Effects on the Brain.

Asfree Gwanyanya1, Christie Nicole Godsmark2, Roisin Kelly-Laubscher3

  • 1Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

CNS & Neurological Disorders Drug Targets
|December 15, 2020
PubMed
Summary

Ethanolamine enhances drug delivery to the brain and may have its own neurological effects. Understanding its CNS actions is crucial for developing new therapies for neurodegenerative diseases.

Keywords:
CNSEthanolaminebrainneuromodulatorphospholipidsprodrugsynaptic

More Related Videos

Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization
08:13

Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization

Published on: May 18, 2020

6.8K
Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

15.0K

Related Experiment Videos

Last Updated: Nov 25, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.3K
Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization
08:13

Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization

Published on: May 18, 2020

6.8K
Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

15.0K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Ethanolamine is a bioactive molecule present in the central nervous system (CNS).
  • Ethanolamine and related compounds act as prodrugs, improving drug transport across the blood-brain barrier.
  • Elevated brain ethanolamine levels may trigger its intrinsic neurological activities.

Purpose of the Study:

  • To review the neurological effects of ethanolamine in the CNS.
  • To explore the implications of ethanolamine's CNS actions for drug design.
  • To highlight the role of ethanolamine in neurodegenerative conditions.

Main Methods:

  • Literature review of studies on ethanolamine in the CNS.
  • Analysis of ethanolamine's role in drug delivery and neurological function.
  • Examination of the link between ethanolamine levels and neurodegeneration.

Main Results:

  • Ethanolamine facilitates drug passage across the blood-brain barrier.
  • Ethanolamine exhibits various beneficial functions in the brain, including cell signaling and molecular storage.
  • Altered ethanolamine levels are associated with neurodegenerative diseases like Alzheimer's disease.

Conclusions:

  • Ethanolamine's dual role in drug delivery and intrinsic neurological action warrants further investigation.
  • Targeting ethanolamine pathways could offer new therapeutic strategies for CNS disorders.
  • Further research into ethanolamine's CNS effects is essential for advancing drug design for neurological conditions.